| Patent application number | Description | Published |
| 20090169532 | CURABLE BONE CEMENT - The present invention describes a curable bone cement. The cement comprises a curable polymeric binder and a filler, and is capable of curing without substantial evolution of heat on exposure to a curing agent. The binder comprises phenol groups which are capable of reacting in order to cure the cement. | 07-02-2009 |
| 20090305983 | Curable Bone Cement - The present invention describes a curable bone cement. The cement comprises a curable polymeric binder and a filler, and is capable of curing without substantial evolution of heat on exposure to a curing agent. The binder comprises phenol groups which are capable of reacting in order to cure the cement. | 12-10-2009 |
| 20100059391 | METHOD FOR DETECTING BIOMOLECULES AND USE THEREOF - Biomolecule-specific probe is immobilized on an electrode surface to form a modified electrode. The modified electrode is exposed to target biomolecule. The biomolecule is captured by the probe whereby a first complex with the biomolecule is formed. Subsequently, the biomolecule is exposed to electroactive label having binding affinity to the biomolecule. The biomolecule adsorbs the electroactive label to the modified electrode to form a working electrode whereby a second complex comprising the first complex with the biomolecule and the bound electroactive label is formed. The working electrode is placed in an electrolyte medium and electrochemical measurement between the working electrode and a reference electrode is taken wherein the electrochemical measurement comprises the measurement of electrical signal resulting from a solid-state electrochemical process involving the electroactive labels. The magnitude of the electrochemical measurement corresponds to the concentration of the biomolecule present in the sample. | 03-11-2010 |
| 20100117029 | FORMING CROSSLINKED-GLUTATHIONE ON NANOSTRUCTURE - In a method of forming a light emissive nanostructure, a quantum dot is provided and a crosslinked-glutathione layer around the quantum dot is formed. The light emissive nanostructure thus comprises a quantum dot and a crosslinked-glutathione layer around the quantum dot. In another method, a metal-based nanostructure is provided, and a crosslinked-glutathione layer coated on a surface of the metal-based nanostructure is formed. The metal-based nanostructure is thus coated with a crosslinked-glutathione layer. To promote crosslinking and stability, the glutathione layer may be crosslinked in the presence of an activating agent and sufficient amount of free glutathione. | 05-13-2010 |
| Patent application number | Description | Published |
| 20080258115 | COATED WATER SOLUBLE NANOPARTICLES - Nanoparticles and methods of making nanoparticles are provided. The nanoparticles may include semiconductor nanocrystals. A shell may encapsulate a nanoparticle core, and the shell may include non-organic material and may be silica. The shell may also include additional species such as PEG. In some embodiments, a passivation layer is in contact with the core. | 10-23-2008 |
| 20090005236 | Mesostructured Zeolitic Materials and Methods of Making and Using the Same - One aspect of the present invention relates to mesostructured zeolites. The invention also relates to a method of preparing mesostructured zeolites, as well as using them as cracking catalysts for organic compounds and degradation catalysts for polymers. | 01-01-2009 |
| 20090090657 | Mesostructured Zeolitic Materials and Methods of Making and Using the Same - One aspect of the present invention relates to mesostructured zeolites. The invention also relates to a method of preparing mesostructured zeolites, as well as using them as cracking catalysts for organic compounds and degradation catalysts for polymers. | 04-09-2009 |
| 20090246167 | STIMULI-RESPONSIVE SYSTEMS FOR CONTROLLED DRUG DELIVERY - A method of delivering a therapeutic agent by providing a cross-linked polymer encapsulating the therapeutic agent to a site in a patient. The degradation rate of the cross-linked polymer is correlated with a local concentration of an indicator, and the therapeutic agent is released as the cross-linked polymer degrades. | 10-01-2009 |
| 20090326177 | Mesostructured Zeolitic Materials and Methods of Making and Using the Same - One aspect of the present invention relates to mesostructured zeolites. The invention also relates to a method of preparing mesostructured zeolites, as well as using them as cracking catalysts for organic compounds and degradation catalysts for polymers. | 12-31-2009 |
| 20100092383 | Mesostructured Zeolitic Materials and Methods of Making and Using the Same - One aspect of the present invention relates to mesostructured zeolites. The invention also relates to a method of preparing mesostructured zeolites, as well as using them as cracking catalysts for organic compounds and degradation catalysts for polymers. | 04-15-2010 |